The pill, to be taken daily for at least two weeks, significantly reduced postpartum depression among new mothers in a…
The deal would bolster the biotech company’s portfolio of treatments for neuromuscular and rare diseases. Source link
The biotech cited the launch of Alzheimer’s drug Leqembi as part of its new focus on big-return products. Source link
© Reuters. FDA converts Biogen and Eisai's Alzheimer's treatment to traditional approval The U.S. Food and Drug Administration (FDA) converted…
Medicare enrollees can get the anti-amyloid treatment as a result of the agency’s full approval. Source link
(RTTNews) - Biogen Inc. (BIIB) reported Phase 1b clinical data showing that the investigational antisense oligonucleotide therapy, BIIB080, reduced soluble…